Kidron Nadav

Kidron Nadav is listed in filings as President and CEO at Oramed Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Mar 31, 2026, including 13 public disclosures. Recent filings connect the profile to Oramed Pharmaceuticals Inc. (ORMP) and Lifeward Ltd. (LFWD). The current snapshot covers public activity from Nov 8, 2024 to Mar 31, 2026. Reported amounts are shown as $148.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.